LEMD2_HUMAN - dbPTM
LEMD2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID LEMD2_HUMAN
UniProt AC Q8NC56
Protein Name LEM domain-containing protein 2
Gene Name LEMD2
Organism Homo sapiens (Human).
Sequence Length 503
Subcellular Localization Nucleus inner membrane
Multi-pass membrane protein . Lamina-associated protein residing in the inner nuclear membrane (INM). Localized exclusively to the nuclear envelope, giving rise to a typical rim-like staining of the nuclear periphery.
Protein Description Involved in nuclear structure organization. [PubMed: 16339967 Required for maintaining the integrity of the nuclear envelope]
Protein Sequence MAGLSDLELRRELQALGFQPGPITDTTRDVYRNKLRRLRGEARLRDEERLREEARPRGEERLREEARLREDAPLRARPAAASPRAEPWLSQPASGSAYATPGAYGDIRPSAASWVGSRGLAYPARPAQLRRRASVRGSSEEDEDARTPDRATQGPGLAARRWWAASPAPARLPSSLLGPDPRPGLRATRAGPAGAARARPEVGRRLERWLSRLLLWASLGLLLVFLGILWVKMGKPSAPQEAEDNMKLLPVDCERKTDEFCQAKQKAALLELLHELYNFLAIQAGNFECGNPENLKSKCIPVMEAQEYIANVTSSSSAKFEAALTWILSSNKDVGIWLKGEDQSELVTTVDKVVCLESAHPRMGVGCRLSRALLTAVTNVLIFFWCLAFLWGLLILLKYRWRKLEEEEQAMYEMVKKIIDVVQDHYVDWEQDMERYPYVGILHVRDSLIPPQSRRRMKRVWDRAVEFLASNESRIQTESHRVAGEDMLVWRWTKPSSFSDSER
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAGLSDLEL
------CCCCCHHHH
27.8622814378
5Phosphorylation---MAGLSDLELRRE
---CCCCCHHHHHHH
38.9523401153
10MethylationGLSDLELRRELQALG
CCCHHHHHHHHHHCC
22.20115482009
26PhosphorylationQPGPITDTTRDVYRN
CCCCCCCHHHHHHHH
18.3228555341
27PhosphorylationPGPITDTTRDVYRNK
CCCCCCHHHHHHHHH
27.9025627689
82PhosphorylationRARPAAASPRAEPWL
CCCCCCCCCCCCCCC
15.3622115753
90PhosphorylationPRAEPWLSQPASGSA
CCCCCCCCCCCCCCC
30.1926074081
94PhosphorylationPWLSQPASGSAYATP
CCCCCCCCCCCCCCC
39.7129978859
96PhosphorylationLSQPASGSAYATPGA
CCCCCCCCCCCCCCC
18.6628796482
98PhosphorylationQPASGSAYATPGAYG
CCCCCCCCCCCCCCC
16.8328796482
100PhosphorylationASGSAYATPGAYGDI
CCCCCCCCCCCCCCC
15.0228796482
104PhosphorylationAYATPGAYGDIRPSA
CCCCCCCCCCCCHHH
22.6528796482
108MethylationPGAYGDIRPSAASWV
CCCCCCCCHHHHHHH
24.7082797205
110PhosphorylationAYGDIRPSAASWVGS
CCCCCCHHHHHHHCC
26.9824173317
113PhosphorylationDIRPSAASWVGSRGL
CCCHHHHHHHCCCCC
23.2424173317
117PhosphorylationSAASWVGSRGLAYPA
HHHHHHCCCCCCCCC
17.3524173317
122PhosphorylationVGSRGLAYPARPAQL
HCCCCCCCCCCHHHH
11.5028152594
134PhosphorylationAQLRRRASVRGSSEE
HHHHHHHHCCCCCCC
15.5522167270
138PhosphorylationRRASVRGSSEEDEDA
HHHHCCCCCCCCCCC
24.8229255136
139PhosphorylationRASVRGSSEEDEDAR
HHHCCCCCCCCCCCC
48.0729255136
147PhosphorylationEEDEDARTPDRATQG
CCCCCCCCCCCCCCC
31.1222167270
152PhosphorylationARTPDRATQGPGLAA
CCCCCCCCCCCCHHH
34.65-
166PhosphorylationARRWWAASPAPARLP
HHHHHHCCCCCCCCC
17.5323927012
174PhosphorylationPAPARLPSSLLGPDP
CCCCCCCHHHHCCCC
37.9029255136
175PhosphorylationAPARLPSSLLGPDPR
CCCCCCHHHHCCCCC
26.1829255136
188PhosphorylationPRPGLRATRAGPAGA
CCCCCCCCCCCCCCH
18.0223403867
192UbiquitinationLRATRAGPAGAARAR
CCCCCCCCCCHHHCC
26.9121890473
264UbiquitinationTDEFCQAKQKAALLE
CHHHHHHHHHHHHHH
26.84-
264MethylationTDEFCQAKQKAALLE
CHHHHHHHHHHHHHH
26.84-
266MethylationEFCQAKQKAALLELL
HHHHHHHHHHHHHHH
34.61-
319AcetylationVTSSSSAKFEAALTW
CCCCCCHHHHHHHHH
45.767710437
352AcetylationELVTTVDKVVCLESA
HEEEEECEEEECCCC
32.0326051181
436PhosphorylationWEQDMERYPYVGILH
HHHHHHHCCEEEEEE
5.8922817900
438PhosphorylationQDMERYPYVGILHVR
HHHHHCCEEEEEEEC
11.45-
453PhosphorylationDSLIPPQSRRRMKRV
HHCCCHHHHHHHHHH
33.2626462736
470PhosphorylationRAVEFLASNESRIQT
HHHHHHHCCCHHCCC
43.1923312004
473PhosphorylationEFLASNESRIQTESH
HHHHCCCHHCCCCHH
38.6423312004
477PhosphorylationSNESRIQTESHRVAG
CCCHHCCCCHHHCCC
36.76-
479PhosphorylationESRIQTESHRVAGED
CHHCCCCHHHCCCCC
21.71-
493PhosphorylationDMLVWRWTKPSSFSD
CEEEEEECCCCCCCC
25.2222167270
494UbiquitinationMLVWRWTKPSSFSDS
EEEEEECCCCCCCCC
35.6221890473
496PhosphorylationVWRWTKPSSFSDSER
EEEECCCCCCCCCCC
45.6422167270
497PhosphorylationWRWTKPSSFSDSER-
EEECCCCCCCCCCC-
36.9822167270
499PhosphorylationWTKPSSFSDSER---
ECCCCCCCCCCC---
42.0229255136
501PhosphorylationKPSSFSDSER-----
CCCCCCCCCC-----
33.7929255136

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of LEMD2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of LEMD2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of LEMD2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of LEMD2_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of LEMD2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography.";
Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.;
Proteomics 8:1346-1361(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-138 AND SER-139, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-134; SER-138; SER-139;SER-166 AND SER-499, AND MASS SPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-499, AND MASSSPECTROMETRY.

TOP